share_log

康寧傑瑞製藥-B：關連交易公告 - 續訂租賃協議

ALPHAMAB-B: CONNECTED TRANSACTION ANNOUNCEMENT - RENEWAL OF THE LEASE AGREEMENT

香港交易所 ·  Mar 28 09:56
Summary by Moomoo AI
康寧杰瑞制薬-B（ALPHAMAB ONCOLOGY）宣布續訂租賃協議，該協議涉及全資附屬公司江蘇康寧杰瑞與蘇州康寧杰瑞之間的物業及設備租賃。原租賃協議將於2024年3月31日到期，續訂協議將租期延長至同年8月31日。租賃物業位於蘇州市，用於生物製劑製造及材料儲存，月租金為人民幣838,900元。該續訂協議符合國際財務報告準則第16號，並被視為一次性關連交易。董事會認為此舉有助於節省搬遷及行政成本，符合公司及股東利益。江蘇康寧杰瑞成立於2015年，專注於腫瘤生物製劑的研發與商業化，而蘇州康寧杰瑞則成立於2008年，專注於治療性生物製劑的研發。蘇州康寧杰瑞的主要股東為徐霆博士，同時也是康寧杰瑞制薬的董事長、執行董事、首席執行官及控股股東。
康寧杰瑞制薬-B（ALPHAMAB ONCOLOGY）宣布續訂租賃協議，該協議涉及全資附屬公司江蘇康寧杰瑞與蘇州康寧杰瑞之間的物業及設備租賃。原租賃協議將於2024年3月31日到期，續訂協議將租期延長至同年8月31日。租賃物業位於蘇州市，用於生物製劑製造及材料儲存，月租金為人民幣838,900元。該續訂協議符合國際財務報告準則第16號，並被視為一次性關連交易。董事會認為此舉有助於節省搬遷及行政成本，符合公司及股東利益。江蘇康寧杰瑞成立於2015年，專注於腫瘤生物製劑的研發與商業化，而蘇州康寧杰瑞則成立於2008年，專注於治療性生物製劑的研發。蘇州康寧杰瑞的主要股東為徐霆博士，同時也是康寧杰瑞制薬的董事長、執行董事、首席執行官及控股股東。
ALPHAMAB ONCOLOGY ANNOUNCED THE RENEWAL OF THE LEASE AGREEMENT, WHICH RELATES TO THE LEASING OF PROPERTY AND EQUIPMENT BETWEEN WHOLLY OWNED SUBSIDIARIES JIANGSU CONNING JERRY AND CONNING JERRY SUZHOU. The original lease agreement expires on March 31, 2024, and the renewal agreement extends the lease until August 31 of the same year. The rental property is located in Suzhou, used for the manufacture of biopharmaceuticals and material storage. The monthly rent is RMB838,900. The renewal agreement complies with International Financial Reporting Criteria No. 16 and is considered a one-time connected transaction. The Board considers this move to help save relocation and administrative costs and is in the best interests of the Company and its shareholders. Founded in 2015, Jiangsu Corningjeri focuses on the R&D and commercialization of tumor biologics, while Suzhou Corningjiri was founded in 2008 to focus on the research and development of therapeutic biologics. The principal shareholder of CorningJerry Suzhou is Dr. Xu Ting, who is also the Chairman, Executive Director, Chief Executive Officer and Managing Shareholder of CorningJerry Pharmaceuticals.
ALPHAMAB ONCOLOGY ANNOUNCED THE RENEWAL OF THE LEASE AGREEMENT, WHICH RELATES TO THE LEASING OF PROPERTY AND EQUIPMENT BETWEEN WHOLLY OWNED SUBSIDIARIES JIANGSU CONNING JERRY AND CONNING JERRY SUZHOU. The original lease agreement expires on March 31, 2024, and the renewal agreement extends the lease until August 31 of the same year. The rental property is located in Suzhou, used for the manufacture of biopharmaceuticals and material storage. The monthly rent is RMB838,900. The renewal agreement complies with International Financial Reporting Criteria No. 16 and is considered a one-time connected transaction. The Board considers this move to help save relocation and administrative costs and is in the best interests of the Company and its shareholders. Founded in 2015, Jiangsu Corningjeri focuses on the R&D and commercialization of tumor biologics, while Suzhou Corningjiri was founded in 2008 to focus on the research and development of therapeutic biologics. The principal shareholder of CorningJerry Suzhou is Dr. Xu Ting, who is also the Chairman, Executive Director, Chief Executive Officer and Managing Shareholder of CorningJerry Pharmaceuticals.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more